ZANTE GREG
Chief Financial Officer
CIK: 1264949
All Transactions
| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Jan 5, 2026 | Viking Therapeutics, Inc. (VKTX) | S | 13,900 | $33.38 | $464,020.92 | View Details Filing |
| Jan 5, 2026 | Viking Therapeutics, Inc. (VKTX) | S | 10,300 | $34.24 | $352,634.92 | View Details Filing |
| Jan 5, 2026 | Viking Therapeutics, Inc. (VKTX) | S | 31,961 | $32.30 | $1,032,180.50 | View Details Filing |
| Jan 5, 2026 | Viking Therapeutics, Inc. (VKTX) | S | 1,500 | $32.09 | $48,133.05 | View Details Filing |
| Jan 2, 2026 | Viking Therapeutics, Inc. (VKTX) | A | 41,000 | $0.00 | $0.00 | View Details Filing |
| Jan 2, 2026 | Viking Therapeutics, Inc. (VKTX) | A | 32,049 | $0.00 | $0.00 | View Details Filing |
| Jan 2, 2026 | Viking Therapeutics, Inc. (VKTX) | A | 91,000 | $0.00 | $0.00 | View Details Filing |